United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - triazolam is indicated for the short-term treatment of insomnia (generally 7–10 days). use for more than 2–3 weeks requires complete reevaluation of the patient (see warnings). prescriptions for triazolam should be written for short-term use (7–10 days) and it should not be prescribed in quantities exceeding a 1-month supply. triazolam tablets are contraindicated in patients with known hypersensitivity to this drug or other benzodiazepines. benzodiazepines may cause fetal damage when administered during pregnancy. an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. transplacental distribution has resulted in neonatal cns depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. triazolam is contraindicated in pregnant women. if there is a likelihood of the patient becoming pregnant while receiving triazolam, she should

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, inc. - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - triazolam tablets are indicated for the short-term treatment of insomnia (generally 7 to 10 days). use for more than 2 to 3 weeks requires complete reevaluation of the patient (see warnings). prescriptions for triazolam should be written for short-term use (7 to 10 days) and it should not be prescribed in quantities exceeding a 1-month supply. triazolam tablets are contraindicated in patients with known hypersensitivity to this drug or other benzodiazepines. benzodiazepines may cause fetal damage when administered during pregnancy. an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. transplacental distribution has resulted in neonatal cns depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. triazolam tablets are contraindicated in pregnant women. if there is a likelihood of the patient becoming pregnant while recei

United States - English - NLM (National Library of Medicine)

a-s medication solutions - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. triazolam is contraindicated in: - patients with known hypersensitivity to triazolam, any of component of triazolam, or other benzodiazepines. reactions consistent with angioedema (involving the tongue, glottis, or larynx), dyspnea, and throat closing have been reported and may be fatal. - concomitant administration of strong cytochrome p450 (cyp 3a) enzyme inhibitors (e.g., ketoconazole, itraconazole, nefazodone, lopinavir, ritonavir) [see warnings and precautions (5.8), drug interactions (7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to triazolam during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for other psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/othermedications/.

United States - English - NLM (National Library of Medicine)

stat rx usa llc - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - triazolam is indicated for the short-term treatment of insomnia (generally 7–10 days). use for more than 2–3 weeks requires complete reevaluation of the patient (see warnings). prescriptions for triazolam should be written for short-term use (7–10 days) and it should not be prescribed in quantities exceeding a 1-month supply. triazolam tablets are contraindicated in patients with known hypersensitivity to this drug or other benzodiazepines. benzodiazepines may cause fetal damage when administered during pregnancy. an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. transplacental distribution has resulted in neonatal cns depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. triazolam is contraindicated in pregnant women. if there is a likelihood of the patient becoming pregnant while receiving triazolam, she should

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

claris lifesciences (uk) limited - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole